Difference between revisions of "Osocimab (BAY-1213790)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "8 PubMed" to "8/ PubMed") |
Warner-admin (talk | contribs) |
||
Line 7: | Line 7: | ||
==Also known as== | ==Also known as== | ||
− | *'''Code name:''' BAY 1213790 | + | *'''Code name:''' BAY-1213790 |
[[Category:Drugs]] | [[Category:Drugs]] |
Revision as of 00:37, 29 July 2023
Mechanism of action
Anti-Factor XIa antibody
Preliminary data
Venous thromboembolism
- FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article PubMed
Also known as
- Code name: BAY-1213790